For the millions who live by the rhythm of lancets and test strips, a patent filed by Apple in early 2021 gestures toward a quieter future — one where a glance at a wristwatch might replace the daily ritual of drawing blood. The technology, rooted in terahertz spectroscopy, would use electromagnetic waves to read glucose concentrations through the skin, asking nothing of the body in return. Whether this vision survives the long passage from patent to product remains an open question, but it speaks to a deeper human longing: to know what is happening inside us without being wounded in the askin
PhoneArena
· Feb 13, 2021
· health
· 3 min de lectura
Medium
Verificación: Caracterizado
Apple Patent Reveals Non-Invasive Blood Glucose Monitoring for Apple Watch
Diabetics currently endure painful daily finger pricks and significant financial burden from expensive test strips for glucose monitoring.
◉
Technology
8621 artículos relacionados
Google Pixel 11 Pro Fold launches with Tensor G6, Gemini AI, and new O…
Business Today · 100% coincidencia
Honor's Robot Phone and Google Pixel 11 Lead Week's Tech Innovation Ra…
Google News · 99% coincidencia
Tech Giants Embrace Nuclear Power to Meet Surging AI Energy Demands
CNBC · 99% coincidencia
AI's Power Hunger Derails Big Tech's Climate Pledges
Fortune · 99% coincidencia
Google to Retire Assistant on Phones, Watches by September 2026
Bangkok Post · 99% coincidencia
Cobertura Relacionada
BBC News · Aug 22
Papers lead on Harry's legal costs ruling, Mandelson probe collapse risk
Saturday's UK papers lead on Prince Harry's privacy case costs ruling, Lord Mandelson's stalled investigation, and MPs' …
GSMArena.com · Aug 22 vivo V70 Lite 4G launches with 8,100mAh battery and IP69 durabilityvivo introduces V70 Lite 4G with Unisoc T7300 chipset, 8,100mAh battery, 6.83-inch AMOLED display, and IP69 water resist…
CNN · Aug 22 AI Decimates China's Microdrama Industry, Displacing Thousands of ActorsAI video generation tools have rapidly displaced live-action microdrama production in China, with 95% of releases now AI…
The Times of India · Aug 22 IISc Researcher Turns Personal Tragedy Into AI-Powered Breast Cancer Detection ToolDr. Geetha Manjunath, an IISc gold medallist and AI researcher, founded NIRAMAI to detect breast cancer early using ther…
Sesgo y Encuadre
⚖
Article presents Apple's patent for non-invasive glucose monitoring with optimistic framing, emphasizing benefits while minimizing technical challenges and competitive context.
Bias Direction
center-right
Confidence
HIGH
Apple-centric promotional framing that emphasizes innovation benefits and patient relief while downplaying technical hurdles, competitive landscape, and regulatory pathways. Uses sympathetic patient narratives to build emotional appeal.
very painful and expensive test
More importantly, they won't have to feel the pain
improved monitoring
help them control their diabetes better
will eventually pay for itself
Competing non-invasive glucose monitoring technologies already in development or market
Regulatory approval timeline and FDA requirements for medical devices
Skeptical expert analysis on feasibility of terahertz spectroscopy at watch scale
Perspectives from diabetes care professionals on clinical validation needs
Cost-benefit analysis compared to existing continuous glucose monitors (CGMs)
Potential limitations or failure scenarios of the technology
Impacto Geopolítico
🌎
Apple's blood glucose monitoring patent has minimal geopolitical implications; primarily a healthcare technology innovation affecting medical device markets and pharmaceutical supply chains.
Escalation Risk
low
Confidence
LOW
United States
European Union
China
Japan
India
Potential shift in medical device industry dominance as tech giants enter healthcare diagnostics; could reduce dependence on traditional medical device manufacturers (Abbott, Roche) and increase Apple's influence in health tech; may accelerate competition between US tech companies and Chinese manufacturers in wearable health devices.
Similar to how smartphone technology disrupted traditional telecommunications and camera industries; tech companies leveraging consumer platforms to enter regulated healthcare markets
Lente Económico
📈
Apple's patent for non-invasive blood glucose monitoring via Apple Watch could disrupt the $7B+ glucose monitoring market by eliminating recurring test strip costs and improving patient compliance.
Market Signal
mixed
Confidence
MED
Medical devices and diagnostics
Healthcare technology
Pharmaceutical supplies (glucose test strips)
Wearable technology
Health insurance and diabetes management
Diabetics could save hundreds annually on test strips while improving health outcomes through better monitoring. However, benefits depend on technology maturation and Apple Watch adoption rates among diabetic populations.
FDA approval pathway for non-invasive glucose monitoring would be required. Potential regulatory scrutiny on accuracy standards. May prompt reimbursement policy changes by insurers. Could accelerate digital health integration into medical practice.